Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

OBJECTIVES: Little is routinely disclosed about the costs of the pivotal clinical trials that provide the key scientific evidence of the treatment benefits of new therapeutic agents. We expand our earlier research to examine why the estimated costs may vary 100-fold. DESIGN: A cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Thomas J, Heyward, James, Anderson, Gerard, Alexander, G Caleb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295430/
https://www.ncbi.nlm.nih.gov/pubmed/32532786
http://dx.doi.org/10.1136/bmjopen-2020-038863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295430/
https://www.ncbi.nlm.nih.gov/pubmed/32532786
http://dx.doi.org/10.1136/bmjopen-2020-038863

Ejemplares similares